Fig. 2From: Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE studyOS in the ipilimumab-treated and non-ipilimumab treated cohorts. IPI ipilimumab, OS overall survivalBack to article page